Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
A gallbladder tumor is a rare condition, which usually spreads to the liver, lymph nodes, and other organs. A Krukenberg tumor, derived from the biliary tract and gallbladder cancers (GBCs), is an uncommon finding in routine clinical practice. Here, a case of a young woman with a Krukenberg tumor related to a previous diagnosis of GBC is reported. Differential diagnosis of an ovarian malignant lesion is challenging for both clinicians and pathologists. In order to provide a proper diagnosis, integrated multidisciplinary management is essential. The occurrence of Krukenberg tumors should be evaluated in the management of GBC, even if this is rare in clinical practice.
References
1.
Meagher N, Wang L, Rambau P, Intermaggio M, Huntsman D, Wilkens L
. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Mod Pathol. 2019; 32(12):1834-1846.
PMC: 8207534.
DOI: 10.1038/s41379-019-0302-0.
View
2.
Goeppert B, Frauenschuh L, Renner M, Roessler S, Stenzinger A, Klauschen F
. BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma. Mod Pathol. 2013; 27(7):1028-34.
DOI: 10.1038/modpathol.2013.206.
View
3.
Riihimaki M, Hemminki A, Sundquist J, Hemminki K
. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016; 6:29765.
PMC: 4945942.
DOI: 10.1038/srep29765.
View
4.
Aloia T, Jarufe N, Javle M, Maithel S, Roa J, Adsay V
. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015; 17(8):681-90.
PMC: 4527853.
DOI: 10.1111/hpb.12444.
View
5.
Primrose J, Fox R, Palmer D, Malik H, Prasad R, Mirza D
. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019; 20(5):663-673.
DOI: 10.1016/S1470-2045(18)30915-X.
View